NEW YORK (GenomeWeb News) – Singapore's PathGen Dx will develop a pathogen detection diagnostic kit based on the Affymetrix GeneChip platform, the companies said today.

PathGen Dx, a spinoff from the Genome Institute of Singapore, plans to develop a test called the PathChip that will detect the presence of more than 70,000 viral and bacterial genomes in human samples and identify co-infecting pathogens.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.